Altasciences Featured Articles

  1. Discovery Studies: An Agile Approach To Early Data For Quicker Decisions 8/6/2025

    This scientific journal explores the value and characteristics of discovery research and presents two case studies on biodistribution under specific experimental conditions.

  2. Central Nervous System (CNS) Drug Development, Simplified 7/9/2025

    Discover a global CNS leader with 200+ studies completed to date and end-to-end drug development expertise—bridging translational gaps and accelerating your path from discovery to delivery.

  3. The Powerful Combination Of Spray Drying And Nanomilling 7/9/2025

    An integrated nanomilling and spray-drying approach reduces particle size, enhances stability, and transforms nanosuspensions into scalable solid forms—boosting dissolution, bioavailability, and therapeutic success.

  4. A Novel Approach For Improved Bioavailability In Solid Dosage Forms 6/10/2025

    Leverage our expertise in nanomilling and spray drying to address low solubility and improve the bioavailability and efficacy of challenging drug compounds.

  5. Studying The Effects Of Drugs On Driving 5/9/2025

    Discover how early clinical cognitive testing and dedicated driving simulation studies can help assess the cognitive functions for safety and efficacy in drug development.

  6. Navigating The Complexities Of CNS-Active Drugs 5/9/2025

    In this article, we provide a detailed overview of the multiple facets you need to consider during the planning and conduct of your CNS-active drug development.

  7. Psychedelics And Entactogens: Challenges Associated With Schedule 1 Therapeutic Development 5/9/2025

    Industry experts explore the regulatory challenges of Schedule 1 drug development, including required studies, specialized assessments, and key formulation and manufacturing considerations.

  8. Advancing Vision Care: Formulation, Manufacture Of Ocular Therapeutics 4/11/2025

    Explore the unique challenges faced in the formulation development of ocular therapies and how they can be overcome to ensure safe, efficient, and targeted treatments for patients.

  9. Safety Assessment For Ophthalmic Products 2/20/2025

    Dive into the world of ophthalmic drug development, where careful considerations in the preclinical phase must be taken to facilitate advancement into first-in-human clinical trials.

  10. Comprehensive Services For Ophthalmic Drug Development 2/20/2025

    To maximize bioavailability while preserving vision and maintaining the structural integrity of the eye, formulation and delivery strategies must be meticulously designed.